Verrucosin

CAS No. 83198-63-4

Verrucosin( ——— )

Catalog No. M39040 CAS No. 83198-63-4

Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Verrucosin
  • Note
    Research use only, not for human use.
  • Brief Description
    Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.
  • Description
    Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    83198-63-4
  • Formula Weight
    344.4
  • Molecular Formula
    C20H24O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (145.18 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nguyen PH, et al. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg Med Chem Lett. 2010;20(14):4128-4131.?
molnova catalog
related products
  • Pseudoginsenoside RT...

    Pseudoginsenoside RT5 has anti-epilepsy, anti-depressant activity by promoting nerve growth and improve cognitive ability.

  • 4-Methylumbelliferyl...

    4-Methylumbelliferyl-β-D-xylopyranoside (4-Methylumbelliferyl-β-D-xyloside) exhibits bursting steady-state kinetics in biological experiments.

  • Difopein TFA (396834...

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.